CLINICAL_TRIALS
research
· 2025-11-25
Clinical Trial Update: Trial of Acebilustat for the Treatment of Upper Arm Lymphedema [Phase 2]
Summary
This document updates on a Phase 2 trial of Acebilustat for lymphedema of the upper arm, with the study currently active but not recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Stanford University | Conditions: Lymphedema of Upper Arm | Phase 2 | Status: ACTIVE_NOT_RECRUITING